During the past decade, Clinical Research Institute of Michigan, LLC conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 27 clinical trials were completed, i.e. on average, 64.3% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 16 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Institute of Michigan, LLC" #1 sponsor was "Pfizer" with 9 trials, followed by "Eli Lilly and Company" with 7 trials sponsored, "Celgene" with 6 trials sponsored, "Janssen Research & Development, LLC" with 6 trials sponsored and "Bausch Health Americas, Inc." with 6 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Institute of Michigan, LLC" #1 collaborator was "Gilead Sciences" with 4 trials as a collaborator, "Athersys, Inc" with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator, "Incyte Corporation" with 1 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Institute of Michigan, LLC" are "Ulcerative Colitis" (18 trials), "Crohn's Disease" (13 trials), "Colitis, Ulcerative" (5 trials), "Crohn Disease" (5 trials) and "Eosinophilic Esophagitis" (3 trials). Many other conditions were trialed in "Clinical Research Institute of Michigan, LLC" in a lesser frequency.

Most popular intervention types in "Clinical Research Institute of Michigan, LLC" are "Drug" (59 trials), "Other" (5 trials), "Biological" (3 trials), "Diagnostic Test" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (39 trials), "Filgotinib" (5 trials), "GED-0301" (4 trials), "Mirikizumab" (4 trials) and "CP-690,550" (3 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Institute of Michigan, LLC" are 62 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clinical Research Institute of Michigan, LLC". undefined are not yet recruiting, 8 are recruiting, 11 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 33 completed trials in Clinical Research Institute of Michigan, LLC, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Institute of Michigan, LLC, 5 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".